Latest filing published 28 Oct 2026 for Impedimed Limited.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Andrew Grant span 2 companies, the busiest being Impedimed Limited and IPD. We count 4 filings; the first trade dates from 2 June 2026 and the latest from 27 October 2026.
The open-market record is one-sided, with 4 purchases and not one sale. The totals do not cover 4 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 28 October 2026 came the latest disclosure, an open-market purchase in Impedimed Limited. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from ASX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations